---
schema_version: "secwatch.filing_event.v1"
accession: "0001815849-24-000035"
form_type: "8-K"
ticker: null
cik: "0001815849"
company_name: "ATI Physical Therapy, Inc."
filed_at: "2024-05-06T23:59:59+00:00"
generated_at: "2026-06-02T22:19:13.975715+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ATI Physical Therapy Q1 revenue $181.5M (+8.7% YoY); Q2 guidance $185-195M

## Summary
- Net revenue $181.5M, up 8.7% vs Q1 2023; net patient revenue $165.4M (+9.7%).
- Visits per Day 23,837 (+5.0%) driven by increased clinical FTE capacity.
- Clinician turnover rate improved to 16% as part of culture and retention efforts.
- Q2 2024 guidance: revenue $185-195M, Adjusted EBITDA $15-20M.
- Other revenue flat at $16.1M vs $16.2M in prior year.

## SEC filing metadata
- accession: 0001815849-24-000035
- form_type: 8-K
- cik: 0001815849
- company_name: ATI Physical Therapy, Inc.
- filed_at: 2024-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815849/000181584924000035/0001815849-24-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815849/000181584924000035/ati-20240506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001815849-24-000035
- JSON: https://secwatch.observer/filing/0001815849-24-000035.json
- Plain text: https://secwatch.observer/filing/0001815849-24-000035.txt

## Key facts
- Earnings Releases
  ATI Physical Therapy, Inc. reported the first quarter ended March 31, 2024 results: revenue $181.5 million. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $181.5 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: are presented after the financial statements at the end of this press release. Commentary on performance results in the first quarter of 2024 is as follows: • Net revenue was $181.5 million compared to $166.9 million in the first quarter of 2023, an increase of 8.7%. ▪ Net patient revenue was $165.4 million compared to $150.8 million in the first quarter of 2023, an
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815849/000181584924000035/0001815849-24-000035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.